Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAA Therapy in Pediatric Chronic Hepatitis C (MMPHCRF)
NCT03481036Unknown
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Jun 2016
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of sofosbuvir, daclatasvir and ledipasvir in hepatitis C (HCV) (3 arms), sponsored by Post Graduate Institute of Medical Education and Research. Primary endpoint: Sustained Virological Response. Status: unknown.
02
Drugs
sofosbuvirdaclatasvirledipasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03481036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03481036.